Division of Genetic Medicine and Clinical Pharmacology Archive — Page 8 of 12
-
April 28, 2022
Studies combine genetic testing, electronic health records to find undiagnosed diseases
Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations. -
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system. -
April 11, 2022
Peptides promote AFib arrhythmia
Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation. -
March 17, 2022
U.S. precision medicine research program releases genomic data
The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants. -
February 24, 2022
VUMC researchers find clue to drug-induced arrhythmias
Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms. -
February 23, 2022
VUMC designated a Tourette syndrome center of excellence
The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence. -
December 2, 2021
Gene discoveries give new hope to people who stutter
New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.